Alignment Healthcare, INC Form 4 insider transactions

Alignment Healthcare Director Joseph S. Konowiecki filed a Form 4 indicating a planned sale of 25,000 common shares at $16 per share on July 31, 2025, under a Rule 10b5-1 plan.

Alignment Healthcare, Inc. President, Dawn Christine Maroney, sold 30,000 shares of common stock for a weighted-average price of $13.4449 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Alignment Healthcare, Inc. CEO John E. Kao reported recent and future stock transactions, including the withholding of shares for tax liabilities and a significant planned sale under a Rule 10b5-1 plan.

Alignment Healthcare's CEO, John E. Kao, filed an amended Form 4 to correct the number of shares withheld for tax liabilities related to the vesting of service-based restricted stock units.

Alignment Healthcare, Inc. CEO John E. Kao reported the sale of 90,000 shares of common stock for approximately $1.3 million, executed under a Rule 10b5-1 trading plan.

Dawn Christine Maroney, President of Alignment Healthcare, Inc., has sold 30,000 shares of common stock for approximately $434,280 under a pre-arranged Rule 10b5-1 trading plan.

Andreas P. Wagner, Chief Human Resources Officer of Alignment Healthcare, Inc., sold 19,399 shares of common stock on June 11, 2025, under a Rule 10b5-1 trading plan.

Alignment Healthcare's Chief Information Officer, Robert L. Scavo, sold a total of 100,863 shares of common stock in early June 2025, pursuant to a Rule 10b5-1 trading plan.

Alignment Healthcare, Inc. CEO John E. Kao has sold 90,000 shares of common stock for approximately $1.37 million, executed under a pre-arranged Rule 10b5-1 trading plan.

Alignment Healthcare, Inc.'s Chief Financial Officer, James M. Head, was granted 81,593 restricted stock units, aligning executive compensation with long-term company performance.

General Atlantic (ALN HLTH), L.P. sold 17,000,000 shares of Alignment Healthcare, Inc. (ALHC) at a price of $15.28 per share on May 19, 2025.

General Atlantic, a major shareholder in Alignment Healthcare, sold 17 million shares of common stock at $15.28 per share on May 19, 2025.

Dawn Christine Maroney, President of Alignment Healthcare, sold shares of common stock on May 14, 2025, under a pre-arranged 10b5-1 trading plan.

Alignment Healthcare's CEO, John Kao, sold 90,000 shares of common stock at an average price of $14.8381 per share under a pre-arranged 10b5-1 trading plan.

Margaret M. McCarthy, a director at Alignment Healthcare, acquired 1,290 restricted stock units on May 7, 2025, which will vest on March 13, 2026, subject to continued service on the board.

Director Joseph S. Konowiecki of Alignment Healthcare, Inc. was granted 12,903 restricted stock units on May 7, 2025, which will vest on March 13, 2026, subject to continued service on the Board.

Joseph S. Konowiecki, a director at Alignment Healthcare, received 17,000 shares of common stock as a discretionary award and amended a previous Form 4 filing to include this transaction.

Christopher J. Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold 25,000 shares of common stock on May 1, 2025, at a weighted-average price of $16.8731 per share.

Dawn Maroney, President of Alignment Healthcare, sold 230,000 shares of common stock at a price of $19.0965 per share on April 14, 2025, according to a recent SEC Form 4 filing.

Alignment Healthcare's CEO, John Kao, sold 90,000 shares of common stock at a price of $19.0969 per share on April 14, 2025, according to a Form 4 filing.

Christopher J. Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold 25,000 shares of common stock on April 1, 2025, at a weighted-average price of $18.4653 per share.

Robert L. Scavo, Chief Information Officer of Alignment Healthcare, sold 2,864 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold 7,225 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Dawn Christine Maroney, President of Alignment Healthcare, sold 11,152 shares of common stock on March 27, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Robert Thomas Freeman, CFO of Alignment Healthcare, sold 6,744 shares of common stock on March 27, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Alignment Healthcare's CEO, John Kao, sold 34,430 shares of common stock on March 27, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Hyong Kim, Chief Medical Officer of Alignment Healthcare, sold 26,734 shares of common stock at a price of $17.2178 per share on March 20, 2025, according to a Form 4 filing.

Andreas P. Wagner, Chief Human Resources Officer of Alignment Healthcare, sold shares to cover tax withholding obligations related to vested stock.

Sebastian Burzacchi, COO of Alignment Healthcare, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Robert L. Scavo, Chief Information Officer of Alignment Healthcare, sold shares of common stock to cover tax withholding obligations related to vested stock awards.